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SUMMARY 
Augmenter of liver regeneration (ALR), a protein produced and released by hepatocytes is 
mitogenic for hepatocytes in vivo but not in vitro suggesting that the effect is mediated by 
nonparenchymal cells. Since mediators produced by Kupffer cells are implicated in hepatic 
regeneration, we investigated receptor for ALR and its functions in rat Kupffer cells. 
2 
Radioligand receptor binding, and ALR-induced GTP/G-protein association, and protein, NO 
and TNF-a synthesis were determined. High affinity receptor for ALR, belonging to the G-
protein family, with Kd of 1.25 ± 0.18 nM and Bmax of 0.26 ± 0.02 fmol/~g DNA was 
identified. ALR increased mRNA and protein expression of inducible nitric oxide (NO) 
synthase, stimulated NO and protein synthesis, and increased the mRNA expression and release 
ofTNF-a. These effects of ALR were mediated via cholera toxin-sensitive G-protein. ALR 
stimulated p38-MAPK activity and nuclear translocation ofNFKB. While inhibitor ofNFKB 
(MG 132) inhibited ALR-induced NO and protein synthesis, MG 132 and p38-MAPK inhibitor 
(SB203580) blocked ALR-induced TNF-a synthesis. Finally, ALR was found to prevent Kupffer 
cell-induced inhibition of DNA synthesis in hepatocytes and to promote hepatic regeneration in 
rats following 40% hepatectomy. These results demonstrate for the first time specific G-protein 
coupled receptor for ALR and its function in Kupffer cells, and suggest that mediators produced 
by the ALR-stimulated Kupffer cells may elicit physiologically important effects on hepatocytes. 
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INTRODUCTION 
Hepatic regeneration that follows a variety of chemical, microbial, physical and viral 
injuries is a remarkable phenomenon that has been investigated extensively in the animal models 
ofliver injury and partial hepatectomy. Multiple endogenously produced and humoral mediators 
orchestrate hepatic regeneration. The search for the molecules involved in hepatocyte replication 
led to the identification of a novel protein named augmenter ofliver regeneration (ALR) in the 
soluble fractions of the hypertrophic rodent and canine livers (1-3). ALR protein was purified 
from the extracts of weanling rat liver (4,5), and its gene cloned in rat, mouse and human (6,7). 
The ALR sequence is highly homologous among various mammalian species. It also exhibits 
high homology, at the gene and protein level, with ERV1 E~ssential for respiration and yegetative 
growth), which is required for the growth and survival of Saccharomyces cerevisiae (6-9). 
The native ALR isolated from the weanling and regenerating animal livers, but not from 
the unmodified adult liver, and cloned ALR were found to be mitogenic and antiatrophic in 
partially hepatectomized rats, and in dogs after portacaval shunt (1-7). However, presence of 
equivalent amounts of ALR mRNA and protein (38-42 kDa) in hepatocytes of hypertrophic and 
resting rat livers (10) suggested that ALR in quiescent hepatocytes is not mitogenic. We recently 
showed that ALR is a survival factor for hepatocytes, and inhibition of its synthesis via antisense 
mRNA transfection causes mitochondrial dysfunction and death via apoptosis/necrosis (11). 
However, ALR is constitutively released by hepatocytes, and is present in significant level in the 
serum that increases shortly after partial hepatectomy (10). These observations suggest that ALR 
may exert actions on nonparenchymal cell types. This hypothesis is supported by the findings 
that rat hepatocytes lack ALR receptor (10,11), and both native (from the hyperplastic rat liver) 
and the recombinant rat ALR (rrALR) do not stimulate mitosis of cultured rat hepatocytes but do 
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so upon administration in vivo (3,10,11). There is strong evidence that mediators produced by 
Kupffer cells playa critical role in hepatic regeneration (12-16). Therefore, we investigated if 
ALR elicits actions on Kupffer cells via specific receptors. The results show high affinity G-
protein-coupled receptor for ALR on rat Kupffer cells, activation of which causes stimulation of 
NO, protein and TNF-a synthesis. 
MATERIALS AND METHODS 
Preparation of Kupffer cells and hepatocytes. The protocols were approved by the IACUC, 
University of Pittsburgh in accordance with the NIH regulations. Kupffer cells were prepared 
essentially as described previously (17) by collagenase/protease digestion of the liver and 
purification by Metrizamide density gradient centrifugation, followed by centrifugal elutriation. 
The cells were suspended in Williams' medium E containing 10% fetal calf serum, 250 units/ml 
penicillin, 250 ~g/m1 streptomycin, and plated at a density of 0.5 x 106 cells/cm2. The medium 
was renewed after 3h, and the following day and cells were used on the third day. Purity of the 
cells as determined by immunostaining for ED2 (Kupffer cells), desmin (stellate cells) and SE-1 
(endothelial cells) was greater than 95% (17). 
Hepatocytes were prepared as described previously (10,11), and suspended (0.25 x 106 
cells/mt) in William's medium E supplemented with 2 mM L-glutamine, penicillin/streptomycin, 
10% FBS, and 1O-6M insulin. Cells were plated at a density of 0.063 x 106/cm2, the medium 
renewed 3h later, and the cells used following overnight incubation. 
Determination of ALR receptor. Recombinant rat ALR (rrALR), prepared as described 
previously (7), was radioiodinated by lactoperoxidase procedure (18). For ALR binding assay, 
the cells were washed and placed in Hank's balanced salt solution (20 mM HEPES, pH 7.0, 1.3 
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mM CaCh, 0.5 mM MgCh) containing 0.1 % BSA (HBSSIBSA) for 30 min. The medium was 
then replaced with HBSS/BSA containing 12.5-3200 pM C25I]ALR (Specific Activity 1400-
1500 j.tCi/mmol) ± 5 j.tM unlabeled rrALR (0.3 ml final volume). After 3h of incubation at 25°C, 
the cells were washed with ice-cold PBS (4X), digested with 0.75 N NaOH, and cell-associated 
radioactivity was determined. Specific binding was calculated as the difference between cell-
associated radioactivity in the presence and absence of unlabeled rrALR. 
To determine whether the ALR receptor belongs to the G-protein superfamily of 
receptors, Kupffer cell membranes were prepared by homogenization with a Polytron 
homogenizer (Ten 5-sec bursts at 20,000 rpm) in ice-cold 20 mM Tris, pH 7.4, containing 0.5 
mM phenylmethylsulfonylfluoride (PM SF) and protease inhibitor cocktail (Sigma #P-8340). The 
homogenate was centrifuged at 6,000g for 5 min followed by centrifugation of the supernatant at 
43,000g for 30 min. The pellet was suspended in 20 mM Tris, pH 7.4, containing protease 
inhibitors and 5 mM MgCh (Buffer A) at a protein concentration of 1 j.tg/j.tl, and frozen at -80°C 
until use. The binding assay was performed in 100 j.tl offinal volume containing buffer A, 10 j.tg 
membrane protein, 3 j.tM GDP, 0.05 pM eSS]GTPyS, and rrALR. Nonspecific binding was 
determined in the presence of excess (10 11M) GTPyS. The reaction was initiated by adding 
membranes, continued at 30°C for specified time, and terminated by adding 3 ml ice-cold buffer 
A followed by rapid filtration on GFIB glass microfiber membranes (Whatman) presoaked in 
buffer A. The membrane was washed (3X) and associated radioactivity was determined. 
Nitric oxide, protein and cytokine synthesis: Kupffer cells were washed and placed in 
William's medium E containing 0.1% BSA and indicated concentrations ofrrALR. After 24h of 
incubation at 37°C, the medium was aspirated for detennination ofN02-, an end product of NO 
metabolism by Griess method (19). The medium was also analyzed by ELISA with kits specific 
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for TNF-a (Pierce Biotechnology, Rockford, IL), TGF-a (Peninsula Laboratories, Belmont, CA) 
and qdc-~ (R&D Systems, Minneapolis, MN). 
To determine protein synthesis, the cells were washed and placed in leucine-free MEM 
containing 1 IlCi/ml eH]leucine. After 4h, the medium was aspirated and cells washed twice 
with ice-cold HBSS, treated with ice-cold 10% trichloroacetic acid (TCA) for 10 min, and 
washed once with TCA followed by 95% ethanol. Cells were digested with 5% SDS to measure 
radioactivity. Total DNA was determined in additional wells using Hoechst reagent (20). 
mRNA expression. The mRNA expression ofTNF-a and iNOS were determined by 
semiquantitative reverse transcriptase polymerase chain reaction as described previously (19). 
Briefly, RNA prepared with a ToTALLY RNA isolation kit (Ambion Inc, Austin, TX), was used 
for the preparation of complementary DNA (cDNA) using Superscript II cDNA synthesis kit 
(Life Technologies). For PCR, cDNA equivalent of 50-150 ng of total RNA was used; the 
expression of f)-actin mRNA were determined to normalize the data. The following sequences 
of primers were used in the PCR reaction: TNF-a- 5'CACGCTCTTCTGTCTACTGA3' (F) and 
5 'GGACTCCGTGATGTCTAAGT3' (R); iNOS-
5' AGAATGTTCCAGAATCCCTCCCTGGACA3' (F) and 
5 'GAGTGAGCTGGTAGGTTCCTGTTG3' (R); and f)-actin-
5'TTCTACAATGAGCTGCGTGTG3' (F) and 5'TTCATGGATGCCACAGGATTC3' (R). 
PCR amplification was performed by initial denaturation at 94°C for 5 min, followed by 30 
cycles (f)-actin) or 35 cycles (TNF-a and iNOS) of denaturation at 94°C for 1 min; annealing for 
1 min at 55°C (TNF-a and f)-actin) or 60°C (iNOS); and extension at noc for Imin for TNF-
a and f)-actin, and 2 min for iNOS; and finally 10 min of final extension at noc. The PCR 
products were resolved in a 1.5% agarose gel and stained with IX SYBR Green I (FMC 
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Biproduct, Rockland, ME). The gels were scanned under blue fluorescence light using a 
phosphorimager and the band intensity was quantified using ImageQuant software (Molecular 
Dynamics, Sunnyvale, CA). 
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Western blot analysis: The cells were washed twice with PBS, and lysed for 30 min in ice-cold 
RIPA buffer (Santa Cruz Biotech) containing 0.5 mM PMSF, 25 ~l/ml of Sigma protease 
inhibitor cocktail and ImM sodium orthovanadate. The lysate was centrifuged at 15,000g (10 
minl4°C). The supernatants containing 1 0-20 ~g protein were subjected to electrophoresis on 
sodium dodecylsulfate polyacrylamide gels. The separated proteins were transferred on to 
Immobilon-P membranes (Millipore, Bedford, MA). The membranes were incubated for 2h at 
room temperature in 1 % BSA in TBS/O.l % Tween-20 to block nonspecific binding, incubated 
with the primary antibodies (1: I ,000 dilution) for 2h at room temperature, washed (4X), 
incubated in appropriate secondary antibodies (1 :50,000 dilution) for 2h at room temperature and 
washed (4X). Detection was achieved using an ECL chemiluminescence kit (Amersham-
Pharmacia). To confirm equal loading, the membranes were stripped to assess the expression of 
actin. 
To determine nuclear translocation ofNFKB, nuclear and cytoplasmic extracts were 
prepared using extraction reagents from Pierce-Endogen (Rockford, IL). Nuclear (5 ~gF and 
cytoplasmic (20 ~gF proteins were separated by 10% SDS-PAGE. Western blotting was 
performed using anti-NFKB p65 antibody (Santa Cruz; 1: 1 000) and secondary antibody (1: 
20,000). 
Partial hepatectomy: Male Lewis (LEW, R T.l l) rats (8-10 weeks old) (Harlan Sprague Dawley, 
Inc., Indianapolis, IN) were maintained in laminar flow, specific-pathogen-free atmosphere with 
a standard diet and water supplied ad libitum. 40% hepatectomy was performed under isoflurane 
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anesthesia as described previously (10), and animals were sacrificed at 24h. Animals were 
administered 50 mg/kg 5-bromo-2'-deoxyuridine (ip) 1h before sacrifice. The number of 
hepatocytes in S-phase was determined by counting BrDU-Iabeled nuclei in randomly selected 
regions around four portal triads in 4 power fields per each portal area (10 portal areas per 
section) as described previously (21). 
RESULTS 
ALR receptor in Kupffer cells: Figure 1 shows the results of saturation binding assay (A) and 
the Scatchard plot derived from these data (B). Bmax was calculated to be 0.26±0.02 fmol/)lg 
DNA and a Kd of 1.25±0.18 nM. eSS]GTPyS binding assay demonstrated that ALR, time- and 
concentration-dependently stimulated association of the radiolabeled nucleotide with G-protein 
in Kupffer cell membranes (Figure 2A, 2B). The association was maximal at 1h and half-
maximal at ALR concentration of 5±2 nM. 
8 
Effect of ALR on NO, protein and TNF-a synthesis: Since NO synthesis via iNOS is an 
important step in several biological processes including liver regeneration (22), we determined 
the effect of ALR on NO production as determined by the release of NO end product N02 in the 
culture medium. ALR stimulated NO synthesis/release in a concentration-dependent manner, 
with half maximal activity at 4±1 nM (Figure 3A). Consistent with this effect, ALR increased the 
expression of iNOS mRNA (Figure 3B) and protein (Figure 3C) in Kupffer cells. 
ALR caused concentration-dependent stimulation of cellular protein synthesis in Kupffer 
cells, which was nearly 70% greater than the basal value at 10 ng/ml ALR (Figure 4), and half 
maximal activity occurred at 2.0±0.3 nM ALR. 
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TNF-a and TGF-p are major cytokines produced by Kupffer cells under inflammatory 
conditions and during liver regeneration (23,24). While TNF-a can support hepatic regeneration, 
and is also apoptotic for hepatocytes under certain conditions, qdc-~ is a potent inhibitor of 
hepatocyte replication as well as a proapoptotic factor. Kupffer cells also synthesize TGF-a, a 
potent hepatocyte mitogen. Since hepatic TNF-a, TGF-a and qdc-~ increase significantly after 
the increase in ALR protein following portacaval shunt surgery in rats (21), we hypothesized that 
ALR might affect their synthesis in Kupffer cells. ALR stimulated TNF-a synthesis 
concentration-dependently with half maximal activity at 1.2±OA nM (Figure 5A), and increased 
its mRNA expression (Figure 5B). However, no change in the TGF-p or TGF-a mRNA or 
protein was observed in ALR- stimulated Kupffer cells (results not shown). 
Since rrALR was expressed and purified from bacterial system (10), and bacterial 
lipopolysaccharide is known to exert the effects described above in Kupffer cells, in all 
experiments polymixin B (an inhibitor ofLPS action) was included. No difference in the effects 
of ALR in the absence or presence of polymixin B was observed. Additionally, proteins from 
empty vector-transfected E. coli were extracted in an identical way, and the final eluate was used 
to stimulate Kupffer cells, which also had no effect. 
Effect of G-protein inhibition on ALR-induced effects: Since ALR stimulated specific 
association of [35S ]GTPyS with the G-protein, we ascertained if inhibition of G-protein, by the 
well-established inhibitors pertussis toxin and cholera toxin (27), modulates ALR's effects. 
Cholera toxin inhibited ALR-stimulated association of eSS]GTPyS with the G-protein much 
strongly as compared to the pertussis toxin (Figure 6A). Cholera toxin but not pertussis toxin 
abrogated ALR-stimulated NO, protein and TNF-a synthesis (Figure 6B, C and D). 
Hepatology 
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Effect of ALR on NFKB and MAP kinases: Many extracellular stimuli elicit a variety of 
cellular responses, including the generation of inflammatory mediators, via nuclear translocation 
ofNFKB and activation of JNK-, ERK- and p38-MAPK. To examine which ofthese signaling 
pathways are involved in ALR's effects, Kupffer cells were pretreated with specific inhibitors 
prior to stimulation with ALR. NFKB inhibition by MG 132 blocked ALR-induced NO (Figure 
7 A), protein (Figure 7B) and TNF-a synthesis (Figure 7C). Identical results were also observed 
with another NFKB inhibitor pyrrolidine dithiocarbamate (not shown). Inhibitors of JNK- and 
ERK kinases did not affect ALR's effects, and inhibition ofp38 kinase only blocked ALR-
induced TNF-a synthesis (Figure 7). Consistent with these observations, ALR stimulated nuclear 
translocation ofNFKB and activation ofp38-MAPK in Kupffer cells (Figure 7D). 
Effect of ALR on hepatocytes via Kupffer cells and in vivo after partial hepatectomy: In 
order to elucidate the physiological relevance of ALR's effects on Kupffer cells, we determined 
hepatocyte DNA synthesis in incubations containing medium conditioned by Kupffer cells in the 
presence of increasing concentrations of ALR. Additionally, effect of exogenously administered 
rrALR on hepatic regeneration after 40% hepatectomy in rats was ascertained. As shown in 
Figure 8A, medium conditioned by Kupffer cells inhibited DNA synthesis in hepatocytes. 
However, when the medium was conditioned in the presence of ALR, there was concentration-
dependent prevention of such inhibition. This effect was not due to TNF-a as this cytokine at 1 
nglml (the highest concentration observed in the medium of ALR-stimulated Kupffer cells) did 
not affect hepatocyte DNA synthesis (not shown). ALR administration to rats that have 
undergone 40% hepatectomy caused increase in BrDU incorporation in hepatocytes (Figure 8B) 
indicating ALR's potential in promoting hepatic regeneration. 
Hepatology 
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Next, we determined if ALR-conditioned Kupffer cell medium influences DNA synthesis 
in hepatocytes challenged with qdc-~ or TGF-a. Medium conditioned by Kupffer cells in the 
absence or presence of ALR did not affect qdc-~-induced inhibition of hepatocyte DNA 
synthesis (Figure 8C). Medium conditioned by Kupffer cells in the absence of ALR completely 
prevented TGF-a-induced stimulation of hepatocyte DNA synthesis but the effect was partial 
when the medium was conditioned in ALR's presence (Figure 8C). 
DISCUSSION 
The present investigation demonstrates presence of high affinity G-protein-coupled ALR 
receptor and its function in Kupffer cells. Kupffer cells were studied as a potential ALR target 
because of their ability to influence hepatic regeneration (14-18). Here, we found that ALR 
stimulates synthesis of NO and TNF-a, but not that ofTGF-a or qdc-~I in Kupffer cells. The 
receptor for ALR was found coupled to the G-protein superfamily, and sensitive to cholera toxin. 
This specificity was confirmed by inhibition of ALR-induced G-protein activation as well as the 
synthesis of NO, protein and TNF-a in the presence of cholera toxin. Pertussis toxin, which 
targets another class ofG-proteins caused modest inhibition ofGTP/G-protein association 
without affecting ALR-induced responses. This raises the possibility of a pertussis toxin-
sensitive component, which might be coupled to other unidentified ALR-stimulated processes in 
Kupffer cells. 
NO is known to play significant role in the hemodynamic and metabolic regulation in 
physiology and pathology of the liver. At high concentrations, NO is cytotoxic and inhibits 
protein synthesis (26), gluconeogenesis (27) and mitochondrial respiration (28) in hepatocytes. 
Attenuation of the LPS-induced mortality in iNOS-deficient mice (29) supports the notion that 
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excessive NO production has detrimental consequences (30). However, there are several 
instances in which lower concentrations of NO were found to be antiapoptotic (31,32) and to 
playa major role in several critical physiological processes (32-34). Thus the modest stimulation 
of NO synthesis by ALR in Kupffer cells observed in our experiments suggests ALR's 
hepatoprotective role. 
Interestingly, ALR also stimulated protein synthesis, and mRNA expression and the 
release ofTNF-a, an important signaling polypeptide in the overall hepatic metabolism. TNF-a 
produced by macrophages induces local effects, including vascular permeability, enhanced 
microbial killing, and increased migration ofneutrophils and macrophages (35,36). TNF-a is not 
a true mitogen for isolated hepatocytes (23,24), but plays significant role as a priming agent in 
the early signaling during hepatic regeneration (37). Stimulation of hepatic DNA synthesis upon 
infusion ofTNF-a in vivo (38,39), and TNF-a-induced transient activation ofNFKB and STAT3 
and a 4-fold increase in the mitogenic response to HGF and TGF-a (37) indicate its importance 
in liver regeneration. However, it is also known that under conditions of transcriptional 
inhibition, TNF-a causes death of hepatocytes via apoptosis (31). In pathological conditions 
involving sepsis and liver failure, TNF-a has been predicted to be an important mediator ofLPS-
induced toxicity (40,41). In fact, the magnitude of LPS-stimulated TNF -a release was about 3-4 
times greater than that by ALR (not shown). These findings suggest that high level ofTNF-a 
produced by LPS-stimulated Kupffer cells reflects pathological situation while significantly less 
stimulation of its synthesis by ALR may be beneficial in hepatic biology. In this regard, 
increased hepatic ALR release with concomitant increase in serum ALR were observed after 
partial hepatectomy in rats (10). This observation, in combination with increased hepatic TNF-a 
post partial hepatectomy suggests a role of ALRI TNF-a pathway in liver regeneration. 
Hepatoiogy 
Page 12 of 31 
Page 13 of 31 Hepatology 
13 
It has been established that the NFKB and p38-MAPK activation are common signaling 
pathways responsible for the final responses to a variety of extracellular stimuli involved in 
hepatic regeneration, inflammation and failure. LPS-induced TNF-a synthesis in Kupffer cells is 
mediated by NFK13 and p38-MAPK (42). In Kupffer cells ALR-stimulated TNF-a synthesis is 
also mediated by p38-MAPK; NFK13 but not p38-MAPK inhibition blocked protein and NO 
synthesis. This suggests the possibility that ALR, via NFK13, stimulates synthesis of other 
proteins that might affect hepatic regeneration. Thus, identification of the additional specific 
proteins synthesized by ALR-stimulated Kupffer cells will reveal its other roles in overall 
hepatic metabolism and regeneration. 
Earlier research provided evidence that ALR is mitogenic in vivo but not in vitro for 
hepatocytes (1-7,10). These observations were confirmed in the present study with rrALR. The 
physiological implications of these observations are evident from the abrogation of the 
production ofinhibitor(s) of hepatocyte DNA synthesis by ALR in Kupffer cells. This effect 
cannot be attributed to ALR-induced synthesis of TNF-a, which at the concentration released by 
ALR-stimulated Kupffer cells, does not affect hepatocyte DNA synthesis, and to TGF-a or TGF-
~ whose expressions are not affected by ALR. NO is a short-lived molecule and thus it is 
unlikely to be present in Kupffer cell-conditioned medium added to hepatocyte culture ruling out 
the possibility that it might be a factor to counter Kupffer cells' inhibitory effect on hepatocytes. 
However, ALR-conditioned Kupffer cell medium did not reverse qdc-~-induced inhibition of 
hepatocyte DNA synthesis, and only modestly reversed the complete inhibition ofTGF-a-
stimulated DNA synthesis caused by Kupffer cell-medium conditioned without ALR. Thus, the 
significantly increased hepatocyte replication by ALR in vivo following partial hepatectomy 
suggests its complex interaction with other nonparenchymal cells in addition to Kupffer cells. In 
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this regard, we observed the presence of ALR receptor, similar to that in Kupffer cells, in hepatic 
stellate cells (Unpublished observation). 
In summary, the results of this study provide the first evidence that ALR, via G-protein-
coupled receptor, may play an important role in hepatic metabolism by causing NO, protein and 
TNF-a synthesis in Kupffer cells. Given the important role of Kupffer cells in the regulation of 
the overall hepatic metabolism via secretory molecules, ALR's effects observed here could be an 
important part of liver pathophysiology. 
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FIGURE LEGENDS 
Figure 1. Binding of ALR to Kupffer cells. The assay was performed as described in the 
Methods section. The values are means of duplicate determinations from a representative 
experiment of 3 repeats. A. Saturation binding. B. Scatchard plot of the data shown in A. 
15 
Figure 2. Binding of GTP to Kupffer cell membranes. Membranes were prepared and 
incubated with the GTP-binding assay mixture containing (A) 1 /lM ALR for indicated time 
points or (B) indicated concentrations of ALR for lh. The reaction was stimulated by addition of 
lO /lg membrane proteins. Details are described in the Methods section. 
Figure 3. Effect of ALR on NO synthesis and iNOS expression. Kupffer cells were incubated 
with indicated concentrations of ALR (A) or 100 nglml ALR (B,C) for 24h in serum-free 
condition. (A) The values (N02 concentration in the culture medium) are means of 3 
independent determinations ± S.D. *p<0.005 vs "0". (B and C) The medium was aspirated and 
RNA extracts and protein lysates were prepared from the cells. RT-PCR and Western analysis 
were performed to determine iNOS expression. Representative gels show the mRNA expression 
of iN OS and ~-actin (B), and protein expression of iN OS and actin (C). Bar graphs show 
relative expression of iNOS mRNA or protein versus that of actin. *p<0.05 vs control 
Figure 4. Effect of ALR on protein synthesis. Kupffer cells were incubated with indicated 
concentrations of ALR for 24h in serum-free condition, and protein synthesis was measured as 
described in Methods. The values are means of3 independent determinations ± S.D. *p<0.05. 
Figure 5. Release ofTNF-a and its mRNA expression in ALR-stimulated Kupffer cells. 
(A) Kupffer cells were stimulated with indicated concentrations of ALR for 24h, and TNF-a 
concentration in the culture medium was determined. *p<0.05 vs control; **p<O.Ol vs control. 
(B) After 24h stimulation with 100 nglm! ALR, cellular RNA was extracted and TNF-a mRNA 
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expression was determined by RT-PCR. The bar graph shows relative expression ofTNF-a vs 
that of p-actin. *p<0.05 vs control. 
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Figure 6. Effect of G-protein inhibition on ALR-induced effects. (A) Kupffer cell 
membranes were incubated with the G-protein association mixture in the presence of 1 11M ALR 
without or with 50 nglml pertussis toxin (PX) or 2.5 Ilg/ml cholera toxin (CX) for 2h, the 
reaction was terminated and membrane associated radioactivity was determined. Values (specific 
eSS]GTPyS association) are differences between the binding in the absence and presence of 
excess unlabeled GTPyS. Other details are provided in the Methods section. (B-D) Kupffer cells 
were pre-incubated for 15 min in the absence or presence of 50 nglml pertussis toxin or 2.5 
Ilglml cholera toxin, then stimulated with 100 nglml ALR. After 24h, NO, protein and TNF-a 
levels were measured. *p<0.05 vs control; **p<O.OOl vs control; ***p<O.Ol vs control. 
Figure 7. Involvement of NFKB and MAPK in ALR-induced NO, protein and TNF-a 
synthesis. Kupffer cells were pre-incubated with 10 11M SB283520 (p38 kinase inhibitor), 
PD98059 (ERK1I2 kinase inhibitor), SP600125 (JNK inhibitor), or MG 132 (NFKB inhibitor) for 
30 min before addition of 100 nglml ALR. At 24h, (A) NO, (B) protein and (e) TNF-a synthesis 
were determined. *p<0.05 vs control; **p<O.Ol vs control; #p<0.005 vs ALR; ##p<O.Ol vs 
ALR. (D) Kupffer cells were incubated for 3h with 100 ng/ml ALR, after which nuclear and 
cytosolic extracts or whole celllysates were prepared for Western analysis. Cytosolic (Cyt) and 
Nuclear (Nyc) expression ofp65-NFKB, and total and phosphorylated p38 in the whole cell 
lysate are shown. Actin expression shows equalloading. 
Figure 8: (A) Effect of ALR-conditioned Kupffer cell medium on hepatocyte DNA 
synthesis. Kupffer cells were incubated with indicated concentrations of ALR for 24h. The 
medium (KCtoHC) was then transferred to the overnight culture ofhepatocytes, and at 24h DNA 
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synthesis was measured via eH]thymidine incorporation assay. Results are means of triplicate 
determinations from a representative experiment performed 3 times with similar results. *p<O.OI 
vs HC; **p<0.05 vs "0" KCtoHC; ***p<O.OI vs "0" KCtoHC. (B) Effect of ALR on hepatic 
regeneration after 40% hepetectomy. Rats (200-240g) underwent 40% hepatectomy. 15 min 
prior to and every 6h after PH, ALR (50 nglkg) was administered. At 23h, 50 nglkg BrDU was 
injected and at 24h, rats were sacrificed, their livers preserved in formalin, and immunostaining 
for BrDU was performed. Lower panel shows BrDU labeled cells/power field ± S.D. *p<0.05 vs 
saline control. (C) Effect of ALR-conditioned Kupffer cell medium on DNA synthesis in 
TGF-p- or TGF-a-challenged hepatocytes. Hepatocytes were placed in unconditioned or 
Kupffer cell-conditioned medium in the absence or presence of 100 nglml ALR. qdc-~ or TGF-
a (both 2 nglml) was added and at 24h, DNA synthesis was determined via eH]thymidine 
incorporation assay. Values are means ± S.D. from triplicate determinations. *p<0.05 vs HC or 
HC/ALR; **p<O.Ol vs control; #p<0.05 vs KCtoHC control; ***p<O.OOI vs control; ##p<0.05 
vs KCtoHC+TGF-a. 
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